Guangdong True Health Medical Technology Development Co., Ltd. (HKG:2697)
Hong Kong · Delayed Price · Currency is HKD 264.40
-12.00 (-4.34%)
Sep 23, 2026, 4:08 PM HKT
HKG:2697 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 460.02 | 182.39 | 83.91 | 122.48 |
Short-Term Investments | 0.94 | 1.09 | 0.8 | 0.39 |
Cash & Short-Term Investments | 491.17 | 183.48 | 84.71 | 122.88 |
Cash Growth | 123.12% | 116.60% | -31.06% | - |
Accounts Receivable | 5.75 | 3.97 | - | - |
Other Receivables | 3.03 | 0 | 3.99 | 0.08 |
Receivables | 8.73 | 4.95 | 3.99 | 0.08 |
Inventory | 40.93 | 40.62 | 21.69 | 8.18 |
Other Current Assets | 10.7 | 9.65 | 3.33 | 3.92 |
Total Current Assets | 551.53 | 238.7 | 113.72 | 135.05 |
Property, Plant & Equipment | 23.19 | 22.85 | 28.62 | 22.26 |
Long-Term Investments | 0.17 | 0.24 | - | - |
Other Intangible Assets | 0.46 | 0.79 | 1.41 | 2.11 |
Long-Term Accounts Receivable | 0.64 | 1.16 | - | - |
Other Long-Term Assets | 17.93 | 17.08 | 11.63 | 6.92 |
Total Assets | 593.92 | 280.82 | 155.38 | 166.34 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 1.71 | 2.78 | 0.89 | 0.06 |
Accrued Expenses | 8.16 | 12.36 | 12.93 | 8.51 |
Short-Term Debt | 7.81 | - | 1.25 | - |
Current Portion of Leases | 5 | 6.12 | 6.36 | 4.78 |
Current Income Taxes Payable | - | 0 | 0 | - |
Current Unearned Revenue | 2.29 | 4.14 | 2.23 | 0.55 |
Other Current Liabilities | 13.74 | 4.71 | 0.95 | 5.49 |
Total Current Liabilities | 38.7 | 30.12 | 24.61 | 19.39 |
Long-Term Leases | 4.11 | 2.94 | 5.31 | 4.11 |
Long-Term Unearned Revenue | 8.26 | 8.2 | 0.01 | 1.09 |
Total Liabilities | 51.08 | 41.26 | 29.93 | 24.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 35.65 | 32.08 | 24.7 | 23.55 |
Retained Earnings | 214.14 | -153.72 | -530.76 | -438.61 |
Comprehensive Income & Other | 293.05 | 361.2 | 631.51 | 556.81 |
Shareholders' Equity | 542.84 | 239.57 | 125.45 | 141.75 |
Total Liabilities & Equity | 593.92 | 280.82 | 155.38 | 166.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 16.91 | 9.06 | 12.92 | 8.89 |
Net Cash (Debt) | 474.26 | 174.42 | 71.79 | 113.99 |
Net Cash Growth | 123.04% | 142.96% | -37.02% | - |
Net Cash Per Share | 14.77 | 5.71 | 2.98 | 5.28 |
Filing Date Shares Outstanding | 35.65 | 32.08 | 24.65 | 21.59 |
Total Common Shares Outstanding | 35.65 | 32.08 | 24.65 | 21.59 |
Working Capital | 512.82 | 208.59 | 89.1 | 115.66 |
Book Value Per Share | 15.23 | 7.47 | 5.09 | 6.56 |
Tangible Book Value | 542.38 | 238.78 | 124.04 | 139.64 |
Tangible Book Value Per Share | 15.22 | 7.44 | 5.03 | 6.47 |
Machinery | - | 24.28 | 21.75 | 15.06 |
Leasehold Improvements | - | 4.25 | 3.97 | 2.86 |